PolyCore Therapeutics
Philadelphia, US · Founded 2022 · Delaware corporation
Biotech
Founders & leadership
CB
Christopher B. CashmanDirector
KB
Kelly BeckMs. Beck is the Chief Executive Officer of the Issuer.
FC
Frederick CalloriDirector
CG
Chris GarabedianDirector
JB
James B. HarrisDirector
Reported raises · per SEC filings
Form D private placements▶$4.7MraisedMar 2022 · 5 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Christopher B. CashmanDirector
- Kelly BeckExecutive Officer, Promoter, Director
- Frederick CalloriDirector
- Chris GarabedianDirector
- James B. HarrisDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.